Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

被引：0
|
作者：
A. Torres
P. Bonanni
W. Hryniewicz
M. Moutschen
R. R. Reinert
T. Welte
机构：
[1] University of Barcelona,Servei de Pneumologia, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBER de Enfermedades Respiratorias (CIBERes)
[2] University of Florence,Department of Health Sciences
[3] National Medicines Institute,Department of Infectious Diseases and General Internal Medicine
[4] CHU de Liège/University of Liège,undefined
[5] Pfizer Vaccines (Medical Development Group and Scientific Affairs),undefined
[6] Klinic für Pneumologie,undefined
[7] Medizinische Hochschule Hannover,undefined
来源：
European Journal of Clinical Microbiology & Infectious Diseases | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 416
页数：1
相关论文
共 50 条
  • [1] Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    Torres, A.
    Bonanni, P.
    Hryniewicz, W.
    Moutschen, M.
    Reinert, R. R.
    Welte, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (01) : 19 - 31
  • [2] Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
    A. Torres
    P. Bonanni
    W. Hryniewicz
    M. Moutschen
    R. R. Reinert
    T. Welte
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 19 - 31
  • [3] Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? (vol 34, pg 19, 2015)
    Torres, A.
    Bonanni, P.
    Hryniewicz, W.
    Moutschen, M.
    Reinert, R. R.
    Welte, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (02) : 415 - 416
  • [4] BioBank Japan and what we have learnt so far
    Okada, Yukinori
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 84 - 85
  • [5] Pediatric Myocarditis: What Have We Learnt So Far?
    Pomiato, Elettra
    Perrone, Marco Alfonso
    Palmieri, Rosalinda
    Gagliardi, Maria Giulia
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (05)
  • [6] What we have done so far and what we can achieve (II)
    Morais, A.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (02) : 51 - 52
  • [7] Pneumococcal vaccination in obstructive airway diseases - what can we expect?
    Rose, M
    Lode, H
    de Roux, A
    Zielen, S
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (09) : 461 - 465
  • [8] Proteomics in aortic aneurysm - What have we learnt so far?
    Abdulkareem, Nada
    Skroblin, Philipp
    Jahangiri, Marjan
    Mayr, Manuel
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (7-8) : 504 - 515
  • [9] Central serous chorioretinopathy: what we have learnt so far
    Wong, Kah Hie
    Lau, Kin Pong
    Chhablani, Jay
    Tao, Yong
    Li, Qing
    Wong, Ian Y.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94 (04) : 321 - 325
  • [10] VCSELs in '98: What we have and what we can expect
    Coldren, LA
    Hegblom, ER
    Akulova, YA
    Ko, J
    Strzelecka, EM
    Hu, SY
    [J]. VERTICAL-CAVITY SURFACE-EMITTING LASERS II, 1998, 3286 : 2 - 16
12345